Cargando…

ATP inhibits Ins(1,4,5)P(3)-evoked Ca(2+) release in smooth muscle via P2Y(1) receptors

Adenosine 5′-triphosphate (ATP) mediates a variety of biological functions following nerve-evoked release, via activation of either G-protein-coupled P2Y- or ligand-gated P2X receptors. In smooth muscle, ATP, acting via P2Y receptors (P2YR), may act as an inhibitory neurotransmitter. The underlying...

Descripción completa

Detalles Bibliográficos
Autores principales: MacMillan, D., Kennedy, C., McCarron, J. G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5704898/
https://www.ncbi.nlm.nih.gov/pubmed/22899721
http://dx.doi.org/10.1242/jcs.108498
_version_ 1783281994681024512
author MacMillan, D.
Kennedy, C.
McCarron, J. G.
author_facet MacMillan, D.
Kennedy, C.
McCarron, J. G.
author_sort MacMillan, D.
collection PubMed
description Adenosine 5′-triphosphate (ATP) mediates a variety of biological functions following nerve-evoked release, via activation of either G-protein-coupled P2Y- or ligand-gated P2X receptors. In smooth muscle, ATP, acting via P2Y receptors (P2YR), may act as an inhibitory neurotransmitter. The underlying mechanism(s) remain unclear, but have been proposed to involve the production of inositol 1,4,5-trisphosphate [Ins(1,4,5)P(3)] by phospholipase C (PLC), to evoke Ca(2+) release from the internal store and stimulation of Ca(2+)-activated potassium (K(Ca)) channels to cause membrane hyperpolarization. This mechanism requires Ca(2+) release from the store. However, in the present study, ATP evoked transient Ca(2+) increases in only ~10% of voltage-clamped single smooth muscle cells. These results do not support activation of K(Ca) as the major mechanism underlying inhibition of smooth muscle activity. Interestingly, ATP inhibited Ins(1,4,5)P(3)-evoked Ca(2+) release in cells that did not show a Ca(2+) rise in response to purinergic activation. The reduction in Ins(1,4,5)P(3)-evoked Ca(2+) release was not mimicked by adenosine and therefore, cannot be explained by hydrolysis of ATP to adenosine. The reduction in Ins(1,4,5)P(3)-evoked Ca(2+) release was, however, also observed with its primary metabolite, ADP, and blocked by the P2Y(1)R antagonist, MRS2179, and the G protein inhibitor, GDPβS, but not by PLC inhibition. The present study demonstrates a novel inhibitory effect of P2Y(1)R activation on Ins(1,4,5)P(3)-evoked Ca(2+) release, such that purinergic stimulation acts to prevent Ins(1,4,5)P(3)-mediated increases in excitability in smooth muscle and promote relaxation.
format Online
Article
Text
id pubmed-5704898
institution National Center for Biotechnology Information
language English
publishDate 2012
record_format MEDLINE/PubMed
spelling pubmed-57048982017-11-28 ATP inhibits Ins(1,4,5)P(3)-evoked Ca(2+) release in smooth muscle via P2Y(1) receptors MacMillan, D. Kennedy, C. McCarron, J. G. J Cell Sci Article Adenosine 5′-triphosphate (ATP) mediates a variety of biological functions following nerve-evoked release, via activation of either G-protein-coupled P2Y- or ligand-gated P2X receptors. In smooth muscle, ATP, acting via P2Y receptors (P2YR), may act as an inhibitory neurotransmitter. The underlying mechanism(s) remain unclear, but have been proposed to involve the production of inositol 1,4,5-trisphosphate [Ins(1,4,5)P(3)] by phospholipase C (PLC), to evoke Ca(2+) release from the internal store and stimulation of Ca(2+)-activated potassium (K(Ca)) channels to cause membrane hyperpolarization. This mechanism requires Ca(2+) release from the store. However, in the present study, ATP evoked transient Ca(2+) increases in only ~10% of voltage-clamped single smooth muscle cells. These results do not support activation of K(Ca) as the major mechanism underlying inhibition of smooth muscle activity. Interestingly, ATP inhibited Ins(1,4,5)P(3)-evoked Ca(2+) release in cells that did not show a Ca(2+) rise in response to purinergic activation. The reduction in Ins(1,4,5)P(3)-evoked Ca(2+) release was not mimicked by adenosine and therefore, cannot be explained by hydrolysis of ATP to adenosine. The reduction in Ins(1,4,5)P(3)-evoked Ca(2+) release was, however, also observed with its primary metabolite, ADP, and blocked by the P2Y(1)R antagonist, MRS2179, and the G protein inhibitor, GDPβS, but not by PLC inhibition. The present study demonstrates a novel inhibitory effect of P2Y(1)R activation on Ins(1,4,5)P(3)-evoked Ca(2+) release, such that purinergic stimulation acts to prevent Ins(1,4,5)P(3)-mediated increases in excitability in smooth muscle and promote relaxation. 2012-08-16 2012-11-01 /pmc/articles/PMC5704898/ /pubmed/22899721 http://dx.doi.org/10.1242/jcs.108498 Text en http://creativecommons.org/licenses/by-nc-sa/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial Share Alike License (http://creativecommons.org/licenses/by-nc-sa/3.0/), which permits unrestricted non-commercial use, distribution and reproduction in any medium provided that the original work is properly cited and all further distributions of the work or adaptation are subject to the same Creative Commons License terms.
spellingShingle Article
MacMillan, D.
Kennedy, C.
McCarron, J. G.
ATP inhibits Ins(1,4,5)P(3)-evoked Ca(2+) release in smooth muscle via P2Y(1) receptors
title ATP inhibits Ins(1,4,5)P(3)-evoked Ca(2+) release in smooth muscle via P2Y(1) receptors
title_full ATP inhibits Ins(1,4,5)P(3)-evoked Ca(2+) release in smooth muscle via P2Y(1) receptors
title_fullStr ATP inhibits Ins(1,4,5)P(3)-evoked Ca(2+) release in smooth muscle via P2Y(1) receptors
title_full_unstemmed ATP inhibits Ins(1,4,5)P(3)-evoked Ca(2+) release in smooth muscle via P2Y(1) receptors
title_short ATP inhibits Ins(1,4,5)P(3)-evoked Ca(2+) release in smooth muscle via P2Y(1) receptors
title_sort atp inhibits ins(1,4,5)p(3)-evoked ca(2+) release in smooth muscle via p2y(1) receptors
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5704898/
https://www.ncbi.nlm.nih.gov/pubmed/22899721
http://dx.doi.org/10.1242/jcs.108498
work_keys_str_mv AT macmilland atpinhibitsins145p3evokedca2releaseinsmoothmuscleviap2y1receptors
AT kennedyc atpinhibitsins145p3evokedca2releaseinsmoothmuscleviap2y1receptors
AT mccarronjg atpinhibitsins145p3evokedca2releaseinsmoothmuscleviap2y1receptors